Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2021-10-01 00:00:00 ET · period of report 2021-09-30 · accession 0001209191-21-058514 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-01 | 2021-09-30 | YARW | Domzalski David | Pres, CEO, Dir | F - Tax | $1.39 | -13.1K | 762.8K | -2% | -$18.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-30 | F | D | 13,096 | $1.39 | 762,815 | D | — | — | (F1) Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units. |